MBRF posts higher revenue despite avian flu trade curbs
Growth in protein demand supports sales, margins and expansion
7 April 2026
1 minute read
By: MBRF reported net revenue of R$164 billion in 2025, up 12% from 2024, as total sales volume rose 4% to 8.2 million tonnes, according to a recent company-issued press release. EBITDA reached R$13.2 billion, with a margin of 8%, while net income totalled R$358 million.
The results come in a year marked by temporary restrictions on international chicken trade due to avian influenza. The company maintained growth in operational indicators and reported savings of R$1 billion through its efficiency programme.
Capital expenditure totalled R$5.3 billion, directed toward expanding production lines, increasing capacity, and automating industrial facilities. MBRF also invested about R$1 billion in acquisitions, including a processed meat plant in Henan province, China, entry into the chilled chicken segment in Saudi Arabia, and a 50% stake in Gelprime.
In its BRF operation, net revenue reached R$65 billion, up 5.8% year-on-year. Domestic sales of processed products rose 7%, supported by an 8% increase in the customer base. In Gulf Cooperation Council markets, processed food volumes reached a record level, with market share rising to 38.6%.
The company reported 230 new certifications in 2025 as part of its geographic diversification strategy. Poultry exports to the European Union resumed late in the year, and the Chinese market reopened following the lifting of avian influenza-related restrictions.
In North America, beef operations generated US$14 billion in revenue, up 11.8%, with EBITDA of US$133 million. In South America, volume rose 15% and net revenue increased 20%, with EBITDA reaching R$2.2 billion, up 28% from 2024.
The company said its diversified global presence and multi-protein portfolio continue to support growth across markets.
